sorry, we can't preview this file
40635_2023_574_MOESM1_ESM.docx (108.26 kB)
Additional file 1 of Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial
journal contribution
posted on 2023-12-09, 04:41 authored by Quirin Notz, Daren K. Heyland, Zheng-Yii Lee, Johannes Menger, Johannes Herrmann, Thilo S. Chillon, Stephen Fremes, Siamak Mohammadi, Gunnar Elke, C. David Mazer, Aileen Hill, Markus Velten, Sascha Ott, Maren Kleine-Brueggeney, Patrick Meybohm, Lutz Schomburg, Christian StoppeAdditional file 1: S1: Outcomes in all patients. S2: Baseline selenium levels in Canada and Germany. S3: Baseline characteristics and outcomes in patients with baseline glomerular filtration rate (GFR) ≥ 90 ml/min/1.73 m2. S4: Baseline characteristics and outcomes in patients with baseline glomerular filtration rate (GFR) < 90 ml/min/1.73 m2. S5: Baseline characteristics and outcomes in patients with selenium baseline levels < 70 µg/l. S6: Baseline characteristics and outcomes in patients with glutathione peroxidase (GPx3) baseline activity < 250 µg/l.
